Delivery Order SPE2DB22D1106-SPE2DB24FFJT1
Award Date
8/26/24
Potential Completion Date
9/17/24
Potential Value
$7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $3,509.16 to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, with a completion date of June 13, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,631.84, is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialized pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of March 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,782.64 Firm Fixed Price Delivery Order is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty pharmaceutical product. The contract has an ultimate completion date of January 2, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,336.98 firm fixed-price delivery order is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS medical products. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,677.52 firm-fixed-price delivery order is for the supply of 4559495371 ZOLADEX 10.8 MG IMPLANT SYRNS, with a completion date of January 24, 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which enables the efficient...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,263.74 firm fixed-price delivery order is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a medical product related to healthcare. The contract has an ultimate completion date of November 6, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,297.50 firm fixed-price contract is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a type of pharmaceutical product. The order has a completion date of July 25, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,578.50 firm-fixed-price delivery order is for the supply of the drug ZOLADEX 10.8 MG IMPLANT SYRNS and does not have a set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,564.32, is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, a medical product. The contract type is Delivery Order with a Firm Fixed Price pricing structure. The ultimate completion date is February 7, 2025. This award is part of a larger Indefinite Delivery Contract...
This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS to the Defense Logistics Agency (DLA). The $6,767.84 firm fixed price delivery order has a completion date of January 11, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide...